Fundraising Overview - The company successfully raised a total of RMB 185,415.74 million by issuing 27,806,800 shares at a price of RMB 66.68 per share, with a net amount of RMB 170,929.30 million after deducting issuance costs of RMB 14,486.45 million [1] Changes in Fundraising Projects - The company decided to reallocate RMB 48 million of unused fundraising to two new projects: a 1,500-ton acyl phosphine oxide series photoinitiator project and a 350-ton hydroxy ketone series photoinitiator project, with the approval from the board and shareholders [2][3] Fund Management and Supervision - The company established special fundraising accounts for the new projects and signed a tripartite supervision agreement with the banks and the sponsor to ensure compliance with fundraising management regulations [3][4] - The special accounts are designated solely for the respective projects, ensuring that funds are not used for other purposes [5][9] Agreement Details - The tripartite agreement outlines the responsibilities of each party, including the management of funds, supervision by the sponsor, and the requirement for monthly account statements [6][7] - The agreement will remain effective until all funds are utilized and the supervision period concludes [8][12]

Group 1 - The company Tianjin Jiuri New Materials Co., Ltd. has signed a tripartite supervision agreement for the management of raised funds [1][4] - The company raised a total of RMB 185,415.74 million by issuing 27,806,800 shares at a price of RMB 66.68 per share, with a net amount of RMB 170,929.30 million after deducting issuance costs [2][3] - The company has allocated RMB 48 million of unused raised funds to two new projects: a 1,500-ton acyl phosphine oxide series photoinitiator project and a 350-ton hydroxy ketone series photoinitiator project [3][4] Group 2 - The tripartite supervision agreement was signed on October 17, 2025, involving Tianjin Jiuri, its wholly-owned subsidiary Inner Mongolia Jiuri New Materials Co., Ltd., and the sponsor and bank [4][6] - The agreement stipulates that the funds must be stored in a special account solely for the designated projects and cannot be used for other purposes [6][10] - The sponsor has the right to supervise the use of the raised funds and must conduct semi-annual inspections of the fund management [7][11]

Core Viewpoint - The company has approved the use of part of its raised funds to provide a loan to its controlling subsidiary, which is aimed at implementing a fundraising investment project, thereby enhancing the efficiency of fund utilization [1][4][9]. Meeting Details - The fifth session of the company's supervisory board was held on October 13, 2025, with all three supervisors present, and the meeting complied with relevant laws and regulations [1][2]. - The supervisory board unanimously approved the proposal to use part of the raised funds for the loan [2]. Fundraising and Loan Details - The company plans to provide a loan of 9 million RMB to its subsidiary, Inner Mongolia Hongyuan Tiancheng Technology Development Co., Ltd., for the implementation of a project to produce 350 tons of hydroxy ketone series photoinitiators annually [4][5]. - The total amount raised from the initial public offering was approximately 1.85 billion RMB, with a net amount of about 1.71 billion RMB after deducting issuance costs [5]. Purpose and Impact of the Loan - The loan is intended to ensure the smooth implementation of the fundraising investment project and aligns with the planned use of raised funds, without altering the intended use or harming shareholder interests [9][11]. - The subsidiary, Hongyuan Tiancheng, is financially stable and poses controllable financial risks [9]. Fund Management - The loan will be managed through a dedicated account for raised funds, with a tripartite supervision agreement signed among the company, the bank, and the sponsor [10]. - The loan interest rate will be determined based on the latest published loan market quotation rate and other factors, with a maximum term of 36 months [6]. Opinions from Supervisory Board and Sponsor - The supervisory board and the sponsor have expressed their agreement with the proposal, confirming compliance with relevant regulations and the company's fundraising management system [12].